Personalis at World Immunotherapy Congress USA 2019: March 3-5, 2019
Kedar Hastak, PhD
Field Application Scientist
Cancer Genomics & Immuno-Oncology
Tuesday, March 5 | 2:20 PM
Comprehensive Immunogenomics for Biomarker Discovery from a Single Sample
- While the success of checkpoint blockade has been promising, it’s increasingly
apparent that predicting patient response to immunotherapies requires a more
robust approach to tumor immunogenomics.
- By combining highly sensitive, exome-scale DNA and RNA sequencing with
advanced analytics, ImmunoID NeXT provides a multidimensional view of the
tumor and the tumor microenvironment (TME) from a single sample
- In this presentation, we’ll discuss the benefits of this unique, innovative design
for immuno-oncology translational research including mastering challenging
samples, utilizing optimized algorithms, and obtaining accurate genomic data for
identifying novel biomarker signatures.